Dear Editors,
We submit our manuscript, "Pathway-level IPF signatures demonstrate robust
reproducibility across independent bulk cohorts under strict leakage control,"
for consideration as a Methodology article in BMC Bioinformatics.
**Scientific Context**
Transcriptomic biomarker studies frequently suffer from inflated replication
signals due to subtle donor/subject leakage, pseudoreplication, or evaluation
designs that fail to test subject-level generalization. We address these issues
with a compact, fully reproducible validation pipeline that quantifies stability
at the pathway level.
**Key Contributions**
Using two independent GEO cohorts (GSE24206: n=17 subjects; GSE53845: n=48 subjects),
we demonstrate:
1. **Rigorous leakage control** (Phase 0 audit + subject-level aggregation)
2. **Robust baseline stability** (LOCO p<0.01 both cohorts, exceeds random controls)
3. **Holdout generalization** (confirmed in GSE24206; borderline in GSE53845 with
   documented case-control imbalance)
4. **Transparent limitation reporting** (directional heterogeneity across cohorts,
   bulk tissue limitations)
All validation scripts, environment specifications, and reproduction instructions
are publicly available at: https://github.com/XyndrilAI/ipf-pathway-validation
**Reproducibility Statement**
We provide complete reproducibility artifacts (RUNBOOK.md, ENVIRONMENT.txt,
requirements.txt) enabling independent verification of all reported results.
**Ethics and Originality**
This work uses only publicly available, de-identified GEO datasets. The manuscript
is original, not under consideration elsewhere. The author declares no competing
interests.
**AI Assistance Disclosure**
Pipeline development was assisted by AI tools (Claude 3.7 Sonnet, GitHub Copilot)
for code optimization and documentation, acknowledged in the manuscript.
Thank you for your consideration. We look forward to your feedback.
Sincerely,
Tony Keltakangas
Software Developer / Independent Researcher
Fusion Dev Group, Finland
fusion@xyndril.dev
February 25, 2026